|
SLC16A10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.128000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.460000E-01 |
| Normal-vs-Stage2 |
1.149980E-01 |
| Normal-vs-Stage3 |
3.694800E-01 |
| Normal-vs-Stage4 |
6.122600E-01 |
| Stage1-vs-Stage2 |
2.260100E-02 |
| Stage1-vs-Stage3 |
8.855600E-01 |
| Stage1-vs-Stage4 |
9.731200E-01 |
| Stage2-vs-Stage3 |
2.969900E-02 |
| Stage2-vs-Stage4 |
9.836000E-02 |
| Stage3-vs-Stage4 |
8.967000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.869350E-01 |
| Normal-vs-AfricanAmerican |
9.829200E-01 |
| Normal-vs-Asian |
1.103030E-01 |
| Caucasian-vs-AfricanAmerican |
5.528200E-01 |
| Caucasian-vs-Asian |
5.087200E-01 |
| AfricanAmerican-vs-Asian |
2.685600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.403400E-01 |
| Normal-vs-Female |
3.410400E-01 |
| Male-vs-Female |
3.134400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.595800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.898630E-01 |
| Normal-vs-Age(61-80Yrs) |
4.008200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.726600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.639600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.665600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.688400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.873700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.628800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.931600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.72120000000642E-05 |
| Classical-VS-Follicular |
5.22049999895913E-08 |
| Classical-VS-Other |
3.149600E-01 |
| Classical-VS-Normal |
4.987700E-02 |
| Tall-VS-Follicular |
1.99784633281297E-12 |
| Tall-VS-Other |
1.433790E-01 |
| Tall-VS-Normal |
3.35259999983961E-07 |
| Follicular-VS-Other |
3.278200E-01 |
| Follicular-VS-Normal |
6.12039999999814E-05 |
| Other-VS-Normal |
7.337600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.341200E-01 |
| Normal-vs-N1 |
1.637680E-02 |
| N0-vs-N1 |
1.262400E-03 |
|
|
